Evoke Pharma (EVOK) Finished Goods (2023 - 2025)
Historic Finished Goods for Evoke Pharma (EVOK) over the last 3 years, with Q3 2025 value amounting to $302044.0.
- Evoke Pharma's Finished Goods rose 2801.67% to $302044.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $302044.0, marking a year-over-year increase of 2801.67%. This contributed to the annual value of $187614.0 for FY2024, which is 5554.01% up from last year.
- Per Evoke Pharma's latest filing, its Finished Goods stood at $302044.0 for Q3 2025, which was up 2801.67% from $347271.0 recorded in Q2 2025.
- Evoke Pharma's Finished Goods' 5-year high stood at $375075.0 during Q1 2025, with a 5-year trough of $93026.0 in Q1 2024.
- Moreover, its 3-year median value for Finished Goods was $248711.5 (2024), whereas its average is $240384.2.
- Examining YoY changes over the last 5 years, Evoke Pharma's Finished Goods showed a top increase of 30319.37% in 2025 and a maximum decrease of 2801.67% in 2025.
- Quarter analysis of 3 years shows Evoke Pharma's Finished Goods stood at $120621.0 in 2023, then soared by 55.54% to $187614.0 in 2024, then skyrocketed by 60.99% to $302044.0 in 2025.
- Its Finished Goods stands at $302044.0 for Q3 2025, versus $347271.0 for Q2 2025 and $375075.0 for Q1 2025.